Loading…
Emcure Pharmaceuticals Limited, a pharmaceutical manufacturer, received an FDA Warning Letter on August 2, 2019, regarding drug products. Based on the limited metadata available, the specific nature of the violations cannot be determined as the detailed subject line was not provided. The letter was issued by the FDA's drug regulatory division, though the specific issuing office is unknown. To understand the full scope and nature of the compliance issues cited, review of the complete Warning Letter would be necessary.